跳至主要内容
临床试验/NCT02516371
NCT02516371Unknown不适用

Lymphocytes Subpopulation and Its Relevance With Tumor Grade and Prognosis in Cancer Patients

DERSHENG SUN2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
2
主要终点
response rate after cancer treatment with chemotherapy

研究概览

简要总结

This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.

详细描述

The host's inflammatory response in the tumor microenvironment could effect cancer progression and prognosis. As components of systemic inflammatory response, lymphocytes, neutrophils, and platelets are being recognised to have an important role in carcinogenesis and tumor progression. To date, a number of peripheral blood-derived inflammation-based scores such as the neutrophil-lymphocyte ratio (NLR), platelet- lymphocyte ratio (PLR) and so on have been proposed as prognostic markers in numerous types of cancers. But, very little is known of their impact in subpopulation of lymphocytes. The investigators try to evaluate the activity of lymphocytes in peripheral blood and find out the relationship among clinical prognosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • cancer patients of Uijeongbu St. Mary's Hospital
  • never treated with chemotherapy
  • Age between 20~80 years-

排除标准

  • treated with chemotherapy before
  • No informed consent form

结局指标

主要结局

response rate after cancer treatment with chemotherapy

时间窗: 6 months after chemotherapy

次要结局

未报告次要终点

研究者

发起方
DERSHENG SUN
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

DERSHENG SUN

Clinical assistant professor

The Catholic University of Korea

研究点 (2)

Loading locations...

相似试验